Finally, we evaluated the sensitivity of UP-ALL13 to therapeutic agents either currently used for the treatment of T-ALL or novel targeted therapies which could be effective in this model of NOTCH1-independent leukemia. Here, NOTCH1 is linked to acute lymphoblastic leukemia.